Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil

Table 4 Serum lipid concentrations during the study

Parameters (mMol/L)	Treatment	Baseline	Endpoint	Change (Difference)
TG	HPL Krill oil	98.02 ± 11.76	94.90 ± 9.25^b	−3.12 ± 5.50
	LPL krill oil	106.2 ± 9.62	101.21 ± 10.41	−4.99 ± 4.74
	Control	99.91 ± 10.02	101.51 ± 10.93	1.60 ± 4.78
HDL	HPL Krill oil	54.52 ± 3.14	59.36 ± 3.25	4.84 ± 1.75
	LPL krill oil	55.48 ± 3.33	57.81 ± 3.76	2.33 ± 1.91
	Control	54.71 ± 3.02	56.65 ± 2.90	1.94 ± 1.12
LDL	HPL Krill oil	94.28 ± 5.47	101.52 ± 7.00^a	7.25 ± 3.67^a
	LPL krill oil	96.93 ± 7.25	100.32 ± 8.27^a	3.40 ± 3.35
	Control	93.89 ± 5.07	92.30 ± 5.70	−1.60 ± 2.79
TC	HPL Krill oil	168.02 ± 6.26	179.61 ± 7.65^a	11.59 ± 4.19^a
	LPL krill oil	173.62 ± 7.06	177.68 ± 9.18	4.06 ± 4.76
	Control	169.56 ± 5.53	169.56 ± 6.06	0.00 ± 3.62
TC/HDL	HPL Krill oil	3.28 ± 0.23	3.22 ± 0.26	1.50 ± 0.42
	LPL krill oil	3.41 ± 0.31	3.34 ± 0.30	1.93 ± 0.58
	Control	3.32 ± 0.22	3.21 ± 0.23	1.96 ± 0.74

Values are expressed as Mean ± SEM. n = 20. ^a and ^b denote significance compared with control and LPL respectively. TG- triglycerides, HDL high density lipoprotein, LDL low density lipoprotein, TC total cholesterol

ISSN: 1476-511X